Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
Share:
More In Business
From Viral Moments to Vital Conversations: Rachel Lindsay & Van Lathan On 'Higher Learning'
Celebrating 5 years of the hit podcast 'Higher Learning' with hosts Rachel Lindsay and Van Lathan on the floor of the New York Stock Exchange. Watch!
Returns, Reimagined: How ReturnPro Uses Smart Tech to Simplify Send-Backs
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Big Business This Week: Big Blue gets bigger, without the blues
IBM is up 20% this year, thanks to AI consulting. Plus: UnitedHealthCare, Boeing, FedEx, Apple, Nissan, Dick's, Burberry, and HBO (Max). Whew!
Walmart warns “higher prices are inevitable”
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
U.S.–China Trade Truce: What It Means and What Comes Next
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
